Study Stopped
The tracker application has been withdrawn by developer and no other suitable tracker application has been identified to replace it.
Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support
1 other identifier
interventional
1
1 country
1
Brief Summary
The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2020
CompletedFirst Posted
Study publicly available on registry
October 6, 2020
CompletedStudy Start
First participant enrolled
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2020
CompletedJanuary 15, 2021
January 1, 2021
Same day
September 30, 2020
January 12, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Change in adherence to home blood pressure monitoring
Proportion of days blood pressure is measured based on data from the blood pressuring monitor
1 month
Change in proportion of participants with a blood pressure <130/80 mm Hg.
Proportion of participants with a blood pressure \<130/80 mm Hg.
1 month
Study Arms (2)
With check-ins
EXPERIMENTALDaily blood pressure monitoring with weekly check-ins
Without check-ins
NO INTERVENTIONDaily blood pressure monitoring without weekly check-ins
Interventions
Weekly check-in phone calls from a pharmacist to review blood pressures and the number of times tested in that week
Eligibility Criteria
You may qualify if:
- years of age and older
- Uncontrolled hypertension (BP \> 130/80 mm Hg)
You may not qualify if:
- non-English speaking patients
- patients without a mobile phone or texting capability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dave Dixon, PharmD
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2020
First Posted
October 6, 2020
Study Start
November 5, 2020
Primary Completion
November 5, 2020
Study Completion
November 5, 2020
Last Updated
January 15, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share